Interprotein Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Interprotein Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10865
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Interprotein Corp (Interprotein) is a drug development company that develops active modulators for protein-protein interaction (PPI) targets. The company offers products such as IL-6 inhibitor, IgE inhibitor, notch1 inhibitor, tubulin polymerization inhibitors, TIM-3 inhibitor, NKG2A, HLA-E and CD94 inhibitor, KIR and HLA-C inhibitor, gp130 inhibitor and RUNX1 and CBFß inhibitor. Its IL-6 inhibitor is used in the treatment of Castleman’s disease, rheumatoid arthritis and juvenile idiopathic arthritis, cachexia, and inflammatory and autoimmune diseases. The company operates through its laboratory located in Kanagawa, Japan. Interprotein is headquartered in Osaka City, Japan.

Interprotein Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Interprotein Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Interprotein Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Interprotein Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Interprotein Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Interprotein Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Interprotein Corp, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Interprotein Enters into R&D Agreement with A.I. Squared 10
Ipsen Enters into Research Agreement with Interprotein 11
Interprotein Enters Into Agreement With Takeda Pharma For PPI Inhibitors 12
RaQualia Pharma Enters Into Research Agreement With Interprotein For PPI Inhibitor 13
Interprotein Corp – Key Competitors 14
Interprotein Corp – Key Employees 15
Interprotein Corp – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Government and Public Interest 17
Feb 08, 2018: Interprotein: Program copyright registration of “the system for predicting pharmacological activity of compounds by AI (deep learning)” 17
Product News 18
May 16, 2018: AI-guided INTENDD, Interprotein’s AI drug discovery platform based on deep learning of binding structures of small molecules and target proteins, is transitioning into a practical stage 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Interprotein Corp, Pharmaceuticals & Healthcare, Key Facts 2
Interprotein Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Interprotein Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Interprotein Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Interprotein Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Interprotein Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Interprotein Enters into R&D Agreement with A.I. Squared 10
Ipsen Enters into Research Agreement with Interprotein 11
Interprotein Enters Into Agreement With Takeda Pharma For PPI Inhibitors 12
RaQualia Pharma Enters Into Research Agreement With Interprotein For PPI Inhibitor 13
Interprotein Corp, Key Competitors 14
Interprotein Corp, Key Employees 15
Interprotein Corp, Other Locations 16

List of Figures
Interprotein Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Interprotein Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Interprotein Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Interprotein Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Interprotein Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Interprotein Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Interprotein Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Interprotein Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Interprotein Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SE-Education Public Company Limited (SE-ED):企業概要、財務及び戦略的SWOT分析
    Summary SE-Education Public Company Limited (SE-ED) is a books retailing company. The company conducts business through bookstores, distribution, publishing, SE-ED learning center, and plearnpattana school. It provides publishing and distribution of books and magazines. SE-ED offers books and magazi …
  • Groupe Le Duff S.A.(Foodservice):企業概要およびSWOT分析
    Summary Canadean's "Groupe Le Duff S.A.(Foodservice): Foodservice - Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, co …
  • BioNano Genomics Inc:医療機器:M&Aディール及び事業提携情報
    Summary BioNano Genomics Inc (BioNano) is a developer of technology platform to analyze the segments of genomic DNA and other structural variations. The company's products include irys chip, saphyr, genome mapping systems and prep kits. Its saphyr offers breakthrough speed and throughput with unmatc …
  • Groupe SMCP S.A.S.:企業の戦略的SWOT分析
    Groupe SMCP S.A.S. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Westover Scientific, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Westover Scientific, Inc. Merge …
  • Sonora Gold & Silver Corp. (SOC):企業の財務及び戦略的SWOT分析
    Summary Sonora Gold & Silver Corp. (Sonora Gold) is a mining exploration company that explores and develops base metal projects. The company was formerly known as Mont Blanc Resources Inc. It explores gold and silver mineral properties. Sonora Gold has mining regions in east Africa, and in the Unite …
  • Mindteck (India) Limited:戦略・SWOT・企業財務分析
    Mindteck (India) Limited - Strategy, SWOT and Corporate Finance Report Summary Mindteck (India) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Pacific Edge Limited (PEB):企業概要、財務及び戦略的SWOT分析
    Summary Pacific Edge Limited (PEB) is a cancer diagnostics company. The company discovers and commercializes diagnostic and prognostic technology for the early detection and monitoring of cancer. It identifies gene and protein signatures for the development of cancer management tools. PEB’s products …
  • Numab Innovation AG-製薬・医療分野:企業M&A・提携分析
    Summary Numab Innovation AG (Numab) designs and develops novel therapeutics for the treatment of severe diseases. The company’s lead program ND007, a bispecific antibody fragment which is being evaluated for the treatment of autoimmune diseases. Numab’s other pipeline drug candidates include ND009, …
  • Autonomous University of Barcelona:製薬・医療:M&Aディール及び事業提携情報
    Summary Autonomous University of Barcelona (UAB) is a public university that offers education, research and knowledge transfer services. The university provides undergraduate, post graduate, masters, doctorates, and foreign undergraduate programs. It offers educational programs in the areas of arts …
  • Credence Systems Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Credence Systems Corporation Me …
  • HTG Molecular Diagnostics Inc (HTGM):製薬・医療:M&Aディール及び事業提携情報
    Summary HTG Molecular Diagnostics Inc (HTG) is a technology company that provides molecular technology solutions. The company provides products such as HTG edge system, HTG edgeseq reagents and HTG edgeseq immuno-oncology biomarker panel assay, among others. It develops assays and reagent systems th …
  • LeMaitre Vascular, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' LeMaitre Vascular, Inc. Mergers …
  • Moorim SP Co., Ltd.:企業の戦略・SWOT・財務分析
    SummaryMoorim SP Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fin …
  • Stemline Therapeutics, Inc. (STML):企業概要、財務及び戦略的SWOT分析
    Summary Stemline Therapeutics, Inc. (Stemline) is a clinical stage biopharmaceutical company. The company develops oncology compounds, which targets both cancer stem cells (CSC’s) and the tumor bulk. Its products pipeline includes SL-301, SL-101, SL-201, SL-501 and SL-601. The company is also develo …
  • Vodafone Qatar Q.S.C.の企業概要及び財務/SWOT分析
    Vodafone Qatar QSC Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Vodafone Qatar QSC annual and quarterly forecasts made by stock market experts. The report also enables dir …
  • Yeda Research and Development Company Ltd:企業のM&A・提携動向(医療分野)
    Summary Yeda Research and Development Company Ltd (Yeda) a subsidiary of Weizmann Institute of Science is a technology transfer company that provides research and science education. The company identifies and assesses research projects with commercial potential, protects the intellectual property of …
  • Alvopetro, Inc. (formerly Fortress Energy Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Alvopetro, Inc. (formerly Fortr …
  • SeaWorld Entertainment, Inc.:企業の戦略・SWOT・財務分析
    SeaWorld Entertainment, Inc. - Strategy, SWOT and Corporate Finance Report Summary SeaWorld Entertainment, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Salzgitter AG:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Salzgitter AG Mergers and Acqui …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆